IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of DaVita Inc. and Advises Investors with Losses to Contact the Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating DaVita Inc. (“DaVita” or the “Company”) (Nasdaq: DVA) concerning possible violations of federal securities laws.

If you purchased or otherwise acquired DaVita shares and would like more information regarding the investigation, we encourage you to click here, or contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

On January 6, 2017, the Wall Street Journal announced DaVita had received subpoenas from federal prosecutors for "the production of information related to charitable premium assistance" regarding the Company’s relationship with the American Kidney Fund, a charity that provides financial assistance for patients undergoing kidney dialysis.

When this information was released to the public, the value of DaVita stock fell, causing investors severe harm.

If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts:

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.